Article Text

Download PDFPDF
Uterine cervix rhabdomyosarcoma: an uncommon entity in an adult patient
  1. Latifa Almusalam1,
  2. Nuorh Alghtani2,
  3. Abdulmohsen Alkushi1,3 and
  4. Haitham Arabi1
  1. 1Department of Pathology & Laboratory Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia
  2. 2Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia
  3. 3King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
  1. Correspondence to Dr Haitham Arabi; mharabi{at}hotmail.com

Abstract

Embryonal rhabdomyosarcoma (ERMS) is a malignant neoplasm mostly affecting the genitourinary system of children and is rarely seen in adults. ERMS in uterine cervix is rare and can be misdiagnosed in adult as adenosarcoma or carcinosarcoma. The use of immunohistochemical staining is highly recommended to make sure that the correct diagnosis is reached. To the best of our knowledge, only seven cases of cervical ERMS in women above the age of 50 have been reported in English literature. Herein, we report a rare case of cervical ERMS in a 50-year-old woman that was initially misdiagnosed as an adenosarcoma.

  • pathology
  • oncology
  • obstetrics and gynaecology
  • cancer intervention

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors LA: drafting and revising the manuscript, as well as approving the final version to be submitted. NA: providing the relevant clinical and follow-up data, revising the manuscript, as well as approving the final version to be submitted. AA: drafting and editing the manuscript, as well as approving the final version to be submitted. HA: providing the pathology images, revising and editing the manuscript, as well as approving the final version to be submitted.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.